The Cooper Companies, Inc. - Common Stock — Bilan (NASDAQ:COO)

Afficher le graphique complet Full chart

Financials

Total de l'actif 6.74 B9.61 B11.49 B11.66 B12.32 B12.39 B Total du passif 2.91 B2.66 B4.32 B4.11 B4.23 B4.16 B Total des capitaux propres 3.82 B6.94 B7.17 B7.55 B8.08 B8.24 B Total du passif et des capitaux propres 6.74 B9.61 B11.49 B11.66 B12.32 B12.39 B Dette totale 1.79 B1.48 B2.76 B2.57 B2.58 B2.5 B Dette nette 1.68 B1.38 B2.62 B2.44 B2.47 B2.39 B

The Cooper Companies, Inc. - Common Stock

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market.

COO

Financials

The Cooper Companies, Inc. - Common Stock

Nouvelles

CooperVision nomme Muru Annamalai président pour la région Asie-Pacifique

What Are Wall Street Analysts' Target Price for Cooper Companies’ Stock?

COO or SAUHY: Which Is the Better Value Stock Right Now?

Tracking Al Gore's Generation Investment Management Portfolio – Q1 2026 Update

Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term

Clene Inc. (CLNN) Reports Q1 Loss, Misses Revenue Estimates

Staar Surgical (STAA) Tops Q1 Earnings and Revenue Estimates

Should Value Investors Buy Cardinal Health (CAH) Stock?

L’action Cooper Companies atteint un plus bas de 52 semaines à 59,99$

10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up

PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin Down

Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates